Baxalta
Baxalta's Overview
Baxalta Incorporated was a global biopharmaceutical company that developed, manufactured, and marketed therapies for hemophilia, immunology, and oncology. It was spun off from Baxter International on July 1, 2015. Baxalta focused on providing innovative treatments for patients with rare and complex conditions. In June 2016, Baxalta was acquired by Shire plc for approximately $32 billion. Shire itself was subsequently acquired by Takeda Pharmaceutical Company in January 2019. Baxalta's legacy products, research pipelines, and manufacturing capabilities are now integrated into Takeda's global operations, particularly within its rare diseases portfolio.
Where is Baxalta's Headquarters?
HQ Function
Served as the central hub for Baxalta's global operations, including corporate strategy, executive leadership, R&D oversight, and administrative functions.
Notable Features:
The Bannockburn location was part of a modern corporate campus, providing office space and facilities suitable for a global biopharmaceutical headquarters.
Work Culture:
As a newly formed entity, Baxalta aimed to cultivate an agile, patient-focused, and innovative work environment, distinct from its Baxter heritage while building on its scientific legacy.
HQ Significance:
The headquarters was pivotal in establishing Baxalta's independent identity after its spin-off and managed its rapid growth and strategic initiatives, including its eventual acquisition by Shire.
Values Reflected in HQ: The choice of a modern corporate campus likely reflected Baxalta's ambition to be a forward-looking leader in biopharmaceuticals, emphasizing innovation and global reach.
Location:
During its time as an independent company, Baxalta had a robust global presence, marketing its products in over 100 countries. Key operational regions included North America, Europe, Latin America, and Asia Pacific. Globally supported functions encompassed research and development (with centers in the US and Europe), complex biologics manufacturing, clinical trial operations, regulatory affairs, and the commercialization of its therapies for rare diseases.
Street Address:
1200 Lakeside Drive
City:
Bannockburn
State/Province:
Illinois
Country:
USA
Baxalta's Global Presence
Vienna, Austria
Address: Industriestrasse 67, A-1221 Vienna, Austria
Served as a cornerstone of Baxalta's European operations, supporting production, R&D, and distribution across the continent and other international markets.
Zug, Switzerland
Address: Gubelstrasse 24, 6300 Zug, Switzerland (Typical address for Shire/Baxalta International HQ functions)
Leveraged Switzerland's strategic location and business environment to manage Baxalta's international commercial presence and expansion efforts in Europe and other global markets.
Cambridge, Massachusetts, USA
Address: Kendall Square area (General location for biotech hub)
This location served as a key R&D center, particularly for Baxalta's efforts to build its oncology pipeline and collaborate with other research institutions and biotech companies.
Buying Intent Signals for Baxalta
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Baxalta
As of April 2025, Baxalta' leadership includes:
Investors of Baxalta
Baxalta has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Baxalta operated as an independent company from July 2015 to June 2016. Key executive appointments occurred during its formation. Upon its acquisition by Shire, the executive team was integrated or transitioned. There have been no executive movements for 'Baxalta' as a standalone entity since its acquisition.
Departures
New Appointments:
Technology (Tech Stack) used by Baxalta
Discover the tools Baxalta uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Baxalta Email Formats and Examples
Email addresses using the @baxalta.com domain are no longer active or valid due to the company's acquisition by Shire and subsequent integration into Takeda. During its operation, Baxalta likely used standard corporate email formats.
Common formats included [first].[last]@baxalta.com or [first_initial][last]@baxalta.com
Format
example: john.doe@baxalta.com
Example
0%
Success rate
News and media
Business Wire • July 1, 2015
Baxalta Launches as Independent Global Biopharmaceutical Company
Baxalta Incorporated (NYSE: BXLT) today announced its launch as an independent global biopharmaceutical company dedicated to developing and marketing innovative therapies in hematology, immunology and oncology....more
Shire plc / PR Newswire (via Reuters) • January 11, 2016
Shire agrees $32 billion deal to buy Baxalta
Shire Plc said it had agreed to buy Baxalta International Inc for $32 billion, creating the world's biggest drugmaker focused on rare diseases after a six-month pursuit....more
Shire plc / Pharmaceutical Technology • June 3, 2016
Shire completes $32bn acquisition of Baxalta
Irish drugmaker Shire has completed the previously announced $32bn acquisition of US-based biopharmaceutical company Baxalta, which focuses on developing treatments for rare diseases....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Baxalta, are just a search away.